APR 24, 2019 10:47 PM PDT

A Shrub Compound Reveals New Avenue for Treatment Addictions

WRITTEN BY: Nouran Amin

A compound found in a native African shrub revealed three major types of the serotonin transporter—a protein in the brain that is implicated in anxiety and depression. The serotonin protein binds to a naturally occurring alkaloid known as ibogaine and is involved in altering brain function.

Using cryo-electron microscopy, OHSU researchers reveal the three major shapes of the serotonin transporter--a protein in the brain linked to anxiety and depression. In this image, a serotonin transporter bound with ibogaine (lime spheres), is found to have outward-open, closed and inward-open shapes. (OHSU)

Through cryo-electron microscopy, scientists revealed the structure of the serotonin transporter in its outward-open, closed and inward-open shapes. The cryo-EM enables scientists to observe molecular interaction near-atomic detail. The serotonin transporter is one of the smallest molecules to be so clearly visualized through cryo-EM. "It means we can target different states of the transporter to modulate its activity," said senior author Eric Gouaux, Ph.D., senior scientist at the OHSU Vollum Institute in Portland, Oregon, and an investigator with the Howard Hughes Medical Institute. "It opens up new thinking of how you might come up with novel molecules to bind to the transporter."

Serotonin is a neurotransmitter that influences much of human behavior and regulates the central nervous system including processes ranging from cardiovascular function to digestion, body temperature, endocrinology and reproduction. It works to shape neurological processes such as sleep, mood, cognition, pain, hunger and aggression. The serotonin transporter serves as the molecular pump for serotonin and works to recycle the neurotransmitter following signaling.

Findings of the study were reported in Nature which describe the mechanism behind how the serotonin receptor binds to ibogaine which can open new possibilities to developing new therapeutics that can stop addiction without the hallucinogenic and harmful properties of ibogaine.

"There's a real need to develop molecules that have these anti-addictive properties," said co-lead author Jonathan Coleman, Ph.D., a researcher in the OHSU Vollum Institute.

"Most antidepressant drugs bind to the outward-open conformation, and our study shows ibogaine can bind to the inward state," said co-lead author Dongxue Yang, Ph.D., a researcher in Gouaux's lab. "It provides many more avenues to design small molecules with anti-addictive properties," Coleman added.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
Injectable Implant Drug Shows Promise for HIV Treatment
In a study published in Nature Communications, alternative treatment was shown to have promising results for HIV as opposed to a daily pill regimen. Scient...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
Genital Herpes Vaccine Works in Rodents
A recent vaccine was developed by scientists at Perelman School of Medicine at the University of Pennsylvania that protects against genital herpes. The vac...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
Researchers Can Now Reverse Skin Cancer
Ten years ago, just 5% of people with advanced melanoma (skin cancer) lived more than five years after being diagnosed. Now however, researchers from the I...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
New Potential Early Stage Treatment for Parkinson's
Parkinson’s Disease is the second most common neurodegenerative condition, affecting 35 million people globally. Currently without a cure, researcher...
DEC 05, 2019
Microbiology
DEC 05, 2019
The Antimicrobial Power of Mucus is Revealed
We produce several liters of mucus every day to cover more than 200 square meters in the human body....
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
New Painkiller More Effective than Opioids Discovered in Mud
Researchers have discovered a new painkiller dubbed to be as effective as opioids, only minus their disadvantages, from a 16-year old mud sample found near...
Loading Comments...